These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19846670)

  • 21. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS; Kotlarski I; Jilbert AR
    Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A teratoma in a duck infected congenitally with duck hepatitis B virus.
    Cullen JM; Newbold JE; Sherman GJ
    Avian Dis; 1991; 35(3):638-41. PubMed ID: 1953589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to duck hepatitis B virus infection.
    Jilbert AR; Kotlarski I
    Dev Comp Immunol; 2000; 24(2-3):285-302. PubMed ID: 10717294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of extracts of ampelopsis sinica roots on DHBVsAg in sera of ducklings].
    Chen K; Li H; Chen Y; Zhang C
    Zhong Yao Cai; 2000 Jan; 23(1):41-2. PubMed ID: 12575118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Virology; 1998 Nov; 251(1):85-95. PubMed ID: 9813205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes.
    Saade F; Buronfosse T; Pradat P; Abdul F; Cova L
    Vaccine; 2008 Sep; 26(40):5159-64. PubMed ID: 18554756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.
    Narayan R; Buronfosse T; Schultz U; Chevallier-Gueyron P; Guerret S; Chevallier M; Saade F; Ndeboko B; Trepo C; Zoulim F; Cova L
    J Gen Virol; 2006 Nov; 87(Pt 11):3225-3232. PubMed ID: 17030856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins.
    Khawaja G; Buronfosse T; Jamard C; Abdul F; Guerret S; Zoulim F; Luxembourg A; Hannaman D; Evans CF; Hartmann D; Cova L
    Virology; 2012 Nov; 433(1):192-202. PubMed ID: 22921316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
    Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
    J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver.
    Barraud L; Douki T; Guerret S; Chevallier M; Jamard C; Trepo C; Wild CP; Cadet J; Cova L
    Cancer Detect Prev; 2001; 25(2):192-201. PubMed ID: 11341355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studying host immune responses against duck hepatitis B virus infection.
    Miller DS; Bertram EM; Scougall CA; Kotlarski I; Jilbert AR
    Methods Mol Med; 2004; 96():3-25. PubMed ID: 14762255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
    Chen G; Chen J; Liu D; Zhang X; Zhu C; Li Y; Wang L; Yang Y; Cai G; Han F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):329-32. PubMed ID: 15617240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrastructural study and localization of duck hepatitis B virus in the livers of experimentally infected ducks].
    Tian P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):108-11. PubMed ID: 1831706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-independent entry and sequential endosomal sorting are major determinants of hepadnaviral infection in primary hepatocytes.
    Funk A; Mhamdi M; Hohenberg H; Will H; Sirma H
    Hepatology; 2006 Sep; 44(3):685-93. PubMed ID: 16941679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duck hepatitis B virus: an invaluable model system for HBV infection.
    Schultz U; Grgacic E; Nassal M
    Adv Virus Res; 2004; 63():1-70. PubMed ID: 15530560
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
    Munshi A; Mehrotra R; Panda SK
    Trop Gastroenterol; 1994; 15(2):77-85. PubMed ID: 7831721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Duck hepatitis B virus (DHBV) and viral DNA in duck hepatocellular carcinoma and liver tissue].
    Yang GX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):249-52. PubMed ID: 1666870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of immune tolerance to hepatitis virus in an animal model.
    Wen YM; Zhang W; Xu YY; Luo YF; Li PY
    Chin Med J (Engl); 1992 Mar; 105(3):199-203. PubMed ID: 1395838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.
    Thermet A; Buronfosse T; Werle-Lapostolle B; Chevallier M; Pradat P; Trepo C; Zoulim F; Cova L
    J Gen Virol; 2008 May; 89(Pt 5):1192-1201. PubMed ID: 18420797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.